Selected research
Industry Research
Paroxetine Industry Research Report 2026
Market perspective
The global Paroxetine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Paroxetine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Paroxetine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Paroxetine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Paroxetine include Teva, Sun Pharmaceutical, Mylan, Aurobindo, Sebela Pharmaceuticals, Neurocon Inc, Lupin, Lifegenix and Lannett Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Paroxetine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Paroxetine Market by Company
Teva
Sun Pharmaceutical
Mylan
Aurobindo
Sebela Pharmaceuticals
Neurocon Inc
Lupin
Lifegenix
Lannett Company
Jubilant Pharma
Apotex
Paroxetine Segment by Type
Paroxetine Hydrochloride Drug
Paroxetine Mesylate Drug
Paroxetine Segment by Application
Depression
Social anxiety disorder
Panic disorder
Others
Paroxetine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paroxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Paroxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paroxetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Paroxetine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Paroxetine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Paroxetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Paroxetine Hydrochloride Drug
- Paroxetine Mesylate Drug
Applications
- Depression
- Social anxiety disorder
- Panic disorder
- Others
Companies covered
- Teva
- Sun Pharmaceutical
- Mylan
- Aurobindo
- Sebela Pharmaceuticals
- Neurocon Inc
- Lupin
- Lifegenix
- Lannett Company
- Jubilant Pharma
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Paroxetine Market Size (2021-2032)
- 2.2.2 Global Paroxetine Sales (2021-2032)
- 2.2.3 Global Paroxetine Market Average Price (2021-2032)
- 2.3 Paroxetine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Paroxetine Hydrochloride Drug
- 2.3.3 Paroxetine Mesylate Drug
- 2.4 Paroxetine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Depression
- 2.4.3 Social anxiety disorder
- 2.4.4 Panic disorder
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Paroxetine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Paroxetine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Paroxetine Revenue of Manufacturers (2021-2026)
- 3.4 Global Paroxetine Average Price by Manufacturers (2021-2026)
- 3.5 Global Paroxetine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Paroxetine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Paroxetine, Product Type & Application
- 3.8 Global Manufacturers of Paroxetine, Established Date
- 3.9 Global Paroxetine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Paroxetine Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Paroxetine Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Paroxetine Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Aurobindo
- 4.4.1 Aurobindo Company Information
- 4.4.2 Aurobindo Business Overview
- 4.4.3 Aurobindo Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Aurobindo Paroxetine Product Portfolio
- 4.4.5 Aurobindo Recent Developments
- 4.5 Sebela Pharmaceuticals
- 4.5.1 Sebela Pharmaceuticals Company Information
- 4.5.2 Sebela Pharmaceuticals Business Overview
- 4.5.3 Sebela Pharmaceuticals Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sebela Pharmaceuticals Paroxetine Product Portfolio
- 4.5.5 Sebela Pharmaceuticals Recent Developments
- 4.6 Neurocon Inc
- 4.6.1 Neurocon Inc Company Information
- 4.6.2 Neurocon Inc Business Overview
- 4.6.3 Neurocon Inc Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Neurocon Inc Paroxetine Product Portfolio
- 4.6.5 Neurocon Inc Recent Developments
- 4.7 Lupin
- 4.7.1 Lupin Company Information
- 4.7.2 Lupin Business Overview
- 4.7.3 Lupin Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lupin Paroxetine Product Portfolio
- 4.7.5 Lupin Recent Developments
- 4.8 Lifegenix
- 4.8.1 Lifegenix Company Information
- 4.8.2 Lifegenix Business Overview
- 4.8.3 Lifegenix Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lifegenix Paroxetine Product Portfolio
- 4.8.5 Lifegenix Recent Developments
- 4.9 Lannett Company
- 4.9.1 Lannett Company Company Information
- 4.9.2 Lannett Company Business Overview
- 4.9.3 Lannett Company Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lannett Company Paroxetine Product Portfolio
- 4.9.5 Lannett Company Recent Developments
- 4.10 Jubilant Pharma
- 4.10.1 Jubilant Pharma Company Information
- 4.10.2 Jubilant Pharma Business Overview
- 4.10.3 Jubilant Pharma Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Jubilant Pharma Paroxetine Product Portfolio
- 4.10.5 Jubilant Pharma Recent Developments
- 4.11 Apotex
- 4.11.1 Apotex Company Information
- 4.11.2 Apotex Business Overview
- 4.11.3 Apotex Paroxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Apotex Paroxetine Product Portfolio
- 4.11.5 Apotex Recent Developments
5 Global Paroxetine Market Scenario by Region
- 5.1 Global Paroxetine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Paroxetine Sales by Region: 2021-2032
- 5.2.1 Global Paroxetine Sales by Region: 2021-2026
- 5.2.2 Global Paroxetine Sales by Region: 2027-2032
- 5.3 Global Paroxetine Revenue by Region: 2021-2032
- 5.3.1 Global Paroxetine Revenue by Region: 2021-2026
- 5.3.2 Global Paroxetine Revenue by Region: 2027-2032
- 5.4 North America Paroxetine Market Facts & Figures by Country
- 5.4.1 North America Paroxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Paroxetine Sales by Country (2021-2032)
- 5.4.3 North America Paroxetine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Paroxetine Market Facts & Figures by Country
- 5.5.1 Europe Paroxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Paroxetine Sales by Country (2021-2032)
- 5.5.3 Europe Paroxetine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Paroxetine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Paroxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Paroxetine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Paroxetine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Paroxetine Market Facts & Figures by Country
- 5.7.1 South America Paroxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Paroxetine Sales by Country (2021-2032)
- 5.7.3 South America Paroxetine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Paroxetine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Paroxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Paroxetine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Paroxetine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Paroxetine Sales by Type (2021-2032)
- 6.1.1 Global Paroxetine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Paroxetine Sales Market Share by Type (2021-2032)
- 6.2 Global Paroxetine Revenue by Type (2021-2032)
- 6.2.1 Global Paroxetine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Paroxetine Revenue Market Share by Type (2021-2032)
- 6.3 Global Paroxetine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Paroxetine Sales by Application (2021-2032)
- 7.1.1 Global Paroxetine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Paroxetine Sales Market Share by Application (2021-2032)
- 7.2 Global Paroxetine Revenue by Application (2021-2032)
- 7.2.1 Global Paroxetine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Paroxetine Revenue Market Share by Application (2021-2032)
- 7.3 Global Paroxetine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Paroxetine Value Chain Analysis
- 8.1.1 Paroxetine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Paroxetine Production Mode & Process
- 8.2 Paroxetine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Paroxetine Distributors
- 8.2.3 Paroxetine Customers
9 Global Paroxetine Analyzing Market Dynamics
- 9.1 Paroxetine Industry Trends
- 9.2 Paroxetine Industry Drivers
- 9.3 Paroxetine Industry Opportunities and Challenges
- 9.4 Paroxetine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst